By Paige Minemyer @ Fierce Healthcare 

The Centers for Medicare & Medicaid Services is developing new payment models aimed at reducing the cost of pricey drug treatments. 

CMS Administrator Seema Verma told Reuters in an interview that the agency is targeting expensive therapies, including gene therapy, for cancer and other diseases. One model under consideration is a system where patients would pay more depending on its success in certain conditions; for example, a patient might be charged extra for a drug that treats breast cancer more effectively than liver or lung cancer, according to the article. 

Read the entire article: Fierce Healthcare